home       
   
 
 
  Biotecnol is a biopharmaceutical company focusing on the discovery, engineering and development of novel multifunctional antibody molecules, directed to key therapeutic targets. Based on its Tribody™ technology, Biotecnol is developing a pipeline of products for application in major disease areas such as oncology.
 
May 15, 2009
 
     
 
Apr 30, 2009
 
     
 
Feb 8, 2009
 
     
Type your email to receive our news :

 
   
 
Meet our delegates at the following events
BioPharm America 2009
September 16 - 18, 2009
San Francisco, CA, USA
Biopartnering Europe 2009
October 11 - 13, 2009
London, UK
BioEurope 2009
November 2 - 4, 2009
Vienna, Austria